Department of Surgery, University of Melbourne, Melbourne, Australia.
St. Vincent's Hospital, Victoria, Australia.
Cancer Prev Res (Phila). 2019 Jun;12(6):383-390. doi: 10.1158/1940-6207.CAPR-18-0443. Epub 2019 Apr 19.
Individualized screening is our logical next step to improve population breast cancer screening in Australia. To explore breast screening participants' views of the current program in Victoria, Australia, examine their openness to change, and attitudes toward an individualized screening model, this qualitative work was performed from a population-based breast screening cohort. This work was designed to inform the development of a decision aid to facilitate women's decisions about participating in individualized screening, and to elicit Australian consumer perspectives on the international movement toward individualized breast screening. A total of 52 women participated in one of four focus groups, and were experienced with screening with 90% of participants having had more than three mammograms. Focus group discussion was facilitated following three main themes: (i) experience of breast screening; (ii) breast cancer risk perception, and (iii) views on individualized screening. Participants had strong, positive, emotional ties to breast screening in its current structure but were supportive, with some reservations, of the idea of individualized screening. There was good understanding about the factors contributing to personalized risk and a wide range of opinions about the inclusion of genetic testing with genetic testing being considered a foreign and evolving domain. Individualized breast screening that takes account of risk factors such as mammographic density, lifestyle, and genetic factors would be acceptable to a population of women who are invested in the current system. The communication and implementation of a new program would be critical to its acceptance and potential success. Reservations may be had in regards to uptake of genetic testing, motivations behind the change, and management of the women allocated to a lower risk category.
个体化筛查是我们提高澳大利亚人群乳腺癌筛查水平的下一步合理措施。为了探索澳大利亚维多利亚州乳腺筛查参与者对当前项目的看法,了解他们对改变的开放程度以及对个体化筛查模式的态度,我们对基于人群的乳腺筛查队列进行了这项定性研究。这项工作旨在为制定决策辅助工具提供信息,以促进女性参与个体化筛查的决策,并了解澳大利亚消费者对个体化乳腺筛查国际运动的看法。共有 52 名女性参加了四个焦点小组中的一个,90%的参与者有三次以上的乳房 X 光检查经验。在以下三个主题的指导下,进行了焦点小组讨论:(i)乳房筛查体验;(ii)乳腺癌风险认知;(iii)对个体化筛查的看法。参与者对当前结构的乳房筛查有着强烈、积极、情感上的联系,但对个体化筛查的想法持支持态度,只是有些保留意见。参与者对导致个性化风险的因素有很好的理解,对纳入基因检测的意见也各不相同,认为基因检测是一个外来的、不断发展的领域。考虑到乳腺密度、生活方式和遗传因素等风险因素的个体化乳腺筛查,将受到对当前系统投入的女性群体的欢迎。新程序的沟通和实施对其接受度和潜在成功至关重要。对于基因检测的接受度、改变背后的动机以及分配到低风险类别的女性的管理,可能存在保留意见。